Observational Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 16, 2022; 10(17): 5655-5666
Published online Jun 16, 2022. doi: 10.12998/wjcc.v10.i17.5655
Table 1 Basic characteristics according to the visual analog scale at 12 h after surgery (mean ± SD)

Total
VAS < 4
VAS ≥ 4
P value
Sex (%)
Female21 (46.7)8 (38.1)13 (54.2)0.44
Male24 (53.3)13 (61.9)11 (45.8)
Age43.2 ± 15.745.0 ± 18.041.5 ± 13.60.60
Symptom duration (yr)6.0 ± 6.34.1 ± 4.97.5 ± 7.00.019
Eckardt score7.6 ± 2.16.7 ± 2.28.4 ± 1.60.013
Esophageal diameter (mm)42.9 ± 10.739.0 ± 10.046.3 ± 10.40.022
Esophageal dilatation classification (%)
20 (44.4)13 (61.9)7 (29.2)0.088
21 (46.7)7 (33.3)14 (58.3)
4 (8.9)1 (4.8)3 (12.5)
Previous treatment (%)
No35 (77.8)19 (90.5)16 (66.7)0.078
Yes10 (22.2)2 (9.5)8 (33.3)
Operative time (min)61.3 ± 18.858.8 ± 16.963.5 ± 20.40.46
Anesthesia time (min)74.1 ± 21.072.1 ± 17.575.8 ± 23.90.73
Tunnel length (cm)12.7 ± 1.212.6 ± 0.612.8 ± 1.50.56
Myotomy length (cm)10.7 ± 1.110.6 ± 0.710.8 ± 1.40.35
Distance from muscle incision ending to cardia (cm)2.1 ± 0.32.0 ± 0.22.2 ± 0.40.22
Fentanyl dosage (ug) (%)
10037 (82.2)16 (76.2)21 (87.5)0.44
1508 (17.8)5 (23.8)3 (12.5)
Remifentanil dosage (ug)265.5 ± 90.8264.8 ± 85.3266.1 ± 97.21.0
Table 2 Univariate and multivariate logistic regression analyses of poor pain control, defined as those whose 12-h visual analog scale score was greater than 3
ParameterUnivariate
Multivariate
OR (95%CI)
P value
OR (95%CI)
P value
Sex0.52 (0.16-1.71)0.283
Age0.99 (0.95-1.02)0.45
Duration1.12 (0.98-1.27)0.091
Eckardt Score1.64 (1.12-2.40)0.0111.82 (1.17-2.84)< 0.001
Esophageal diameter1.07 (1.01-1.14)0.028
Esophageal dilatation classification3.71 (1.02-13.51)0.046
5.57 (0.48-64.09)0.17
Previous treatment4.75 (0.88-25.65)0.077.59 (1.12-51.23)0.037
Operative time1.01 (0.98-1.05)0.40
Anesthesia time1.01 (0.98-1.04)0.55
Tunnel length1.18 (0.69-2.01)0.54
Myotomy length1.20 (0.69-2.09)0.52
Distance from muscle incision ending to cardia4.00 (0.41-39.00)0.231.52 (0.79-293.93)0.072
Fentanyl dosage0.46 (0.095-2.20)0.33
Remifentanil dosage1.00 (0.99-1.01)0.96
Table 3 Repeated measures analysis of variance of visual analog scale and sleep scores


F value
P value
VASGroups7.330.0097
Time226.47< 0.001
Groups: Time3.030.019
Sleep scoreGroups4.350.043
Time138.57< 0.001
Groups: Time4.720.035
Table 4 Simple effect analysis of variance of visual analog scale and sleep scores


F value
P value
VASRisk (2 h)8.340.005
Risk (6 h)5.710.019
Risk (12 h)12.91< 0.001
Risk (24 h)1.420.24
Risk (36 h)0.690.41
Sleep scoreRisk (day 1)8.050.006
Risk (day 2)0.800.375